These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 3524050)
41. Live attenuated influenza A virus vaccines in children: results of a field trial. Belshe RB; Van Voris LP; Bartram J; Crookshanks FK J Infect Dis; 1984 Dec; 150(6):834-40. PubMed ID: 6501927 [TBL] [Abstract][Full Text] [Related]
42. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses. Rodriguez L; Nogales A; Murcia PR; Parrish CR; MartÃnez-Sobrido L Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557 [TBL] [Abstract][Full Text] [Related]
43. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. Clover RD; Crawford S; Glezen WP; Taber LH; Matson CC; Couch RB J Infect Dis; 1991 Feb; 163(2):300-4. PubMed ID: 1988512 [TBL] [Abstract][Full Text] [Related]
44. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910 [TBL] [Abstract][Full Text] [Related]
45. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. Gruber WC; Campbell PW; Thompson JM; Reed GW; Roberts B; Wright PF J Infect Dis; 1994 Feb; 169(2):241-7. PubMed ID: 8106759 [TBL] [Abstract][Full Text] [Related]
46. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391 [TBL] [Abstract][Full Text] [Related]
47. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042 [TBL] [Abstract][Full Text] [Related]
49. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers. Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472 [TBL] [Abstract][Full Text] [Related]
50. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Cox NJ; Maassab HF; Kendal AP Virology; 1979 Aug; 97(1):190-4. PubMed ID: 473592 [No Abstract] [Full Text] [Related]
51. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754 [TBL] [Abstract][Full Text] [Related]
52. Characterization and clinical evaluation of live influenza A vaccine prepared from a recombinant of the A/USSR/92/77 (H1N1) and the cold-adapted A/Ann Arbor/6/60 (H2N2) strains. van Voorthuizen F; Jens D; Saes F Antiviral Res; 1981 Jun; 1(2):107-22. PubMed ID: 7039499 [TBL] [Abstract][Full Text] [Related]
53. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N; Laufer J J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [TBL] [Abstract][Full Text] [Related]
54. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
55. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310 [TBL] [Abstract][Full Text] [Related]
56. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910 [TBL] [Abstract][Full Text] [Related]
57. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Beyer WE; Palache AM; de Jong JC; Osterhaus AD Vaccine; 2002 Jan; 20(9-10):1340-53. PubMed ID: 11818152 [TBL] [Abstract][Full Text] [Related]
58. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. Gross PA; Ennis FA; Gaerlan PF; Denson LJ; Denning CR; Schiffman D J Infect Dis; 1977 Nov; 136(5):623-32. PubMed ID: 335000 [TBL] [Abstract][Full Text] [Related]
59. [The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Medvedeva TE; Romanova IuR; Gushchina MI; Rudenko LG; Gendon IuZ; Aleksandrova GI; Klimov AI Vopr Virusol; 1990; 35(2):101-5. PubMed ID: 1697128 [TBL] [Abstract][Full Text] [Related]
60. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center. Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]